BlackRock’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $445M | Buy |
|
|||||
|
2025
Q2 | $383M | Buy |
|
|||||
|
2025
Q1 | $396M | Buy |
|
|||||
|
2024
Q4 | $325M | Sell |
|
|||||
|
2024
Q3 | $479M | Sell |
|
|||||
|
2024
Q2 | $547M | Buy |
|
|||||
|
2024
Q1 | $456M | Buy |
|
|||||
|
2023
Q4 | $440M | Buy |
|
|||||
|
2023
Q3 | $430M | Buy |
|
|||||
|
2023
Q2 | $452M | Sell |
|
|||||
|
2023
Q1 | $629M | Sell |
|
|||||
|
2022
Q4 | $821M | Buy |
|
|||||
|
2022
Q3 | $606M | Sell |
|
|||||
|
2022
Q2 | $789M | Buy |
|
|||||
|
2022
Q1 | $495M | Buy |
|
|||||
|
2021
Q4 | $357M | Sell |
|
|||||
|
2021
Q3 | $499M | Buy |
|
|||||
|
2021
Q2 | $490M | Sell |
|
|||||
|
2021
Q1 | $687M | Buy |
|
|||||
|
2020
Q4 | $603M | Buy |
|
|||||
|
2020
Q3 | $381M | Sell |
|
|||||
|
2020
Q2 | $390M | Buy |
|
|||||
|
2020
Q1 | $298M | Buy |
|
|||||
|
2019
Q4 | $223M | Buy |
|
|||||
|
2019
Q3 | $190M | Sell |
|
|||||
|
2019
Q2 | $192M | Sell |
|
|||||
|
2019
Q1 | $189M | Sell |
|
|||||
|
2018
Q4 | $192M | Sell |
|
|||||
|
2018
Q3 | $256M | Sell |
|
|||||
|
2018
Q2 | $232M | Sell |
|
|||||
|
2018
Q1 | $232M | Buy |
|
|||||
|
2017
Q4 | $221M | Sell |
|
|||||
|
2017
Q3 | $238M | Buy |
|
|||||
|
2017
Q2 | $203M | Sell |
|
|||||
|
2017
Q1 | $215M | Buy |
|
|||||
|
2016
Q4 | $66K | Sell |
|
|||||
|
2016
Q3 | $7.26M | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $87K | Sell |
|
|||||
|
2015
Q3 | $1.28M | Sell |
|
|||||
|
2015
Q2 | $2.54M | Sell |
|
|||||
|
2015
Q1 | $2.8M | Sell |
|
|||||
|
2014
Q4 | $2.9M | Buy |
|
|||||
|
2014
Q3 | $503K | Sell |
|
|||||
|
2014
Q2 | $547K | Buy |
|